| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |